Franklin Electric Co. Inc. (FELE) Jumps 5.01% on January 14

Equities Staff |

Franklin Electric Co. Inc. (FELE) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 5.01% to $25.13, representing a gain of $1.2 per share. Some 284,619 shares traded hands on 2,696 trades, compared with an average daily volume of 282,583 shares out of a total float of 46.36 million. The stock opened at $24.11 and traded with an intraday range of $25.14 to $23.77.

After today's gains, Franklin Electric Co. Inc. reached a market cap of $1.17 billion. Franklin Electric Co. Inc. has had a trading range between $39.84 and $22.71 over the last year, and it had a 50-day SMA of $29.96 and a 200-day SMA of $31.20.

The stock has a P/E Ratio of 20.5.

Franklin Electric Co along with its subsidiaries designs, manufactures and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls and related parts and equipment.

Franklin Electric Co. Inc. is based out of Fort Wayne, IN and has some 4,900 employees. Its CEO is Gregg C. Sengstack.

For a complete fundamental analysis analysis of Franklin Electric Co. Inc., check out’s Stock Valuation Analysis report for FELE. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…